Dermal Fillers in Orange County
Dermal Fillers in Orange County
Rejuvenate & Add Volume
Dermal fillers treatments are one of the best ways to add or restore volume where it needs to be. From a plumper pout to fuller cheeks, the results of fillers are immediate and impressive. At the Med Lounge, we exclusively use hyaluronic acid-based JUVÉDERM, the best facial filler offering the instant results you crave. Reactions are rare as what we’re using is naturally occurring in the body. And dermal fillers come with the added benefit of a collagen boost to improve effects over time.
Our expert team at the Med Lounge offers dermal fillers in Orange County that will add volume where you need it and improve the look and feel of your skin.
Benefits of Dermal Fillers
Immediate results
No downtime
Long-lasting results
Near-zero risk of reaction
Natural results
Fuller cheeks
Reduced wrinkles
Plumper lips
Improved scars
Confidence boost
Frequently Asked Questions
JUVÉDERM dermal fillers can be used for:
- Filling out cheeks
- Plumping up lips
- Filling in smile lines
- Improving skin elasticity
- Defining the chin and jawline
- Reducing acne scarring
- Improving hollow areas under eyes
Whether you’re noticing the effects of aging or are just looking to enhance your natural features, Dermal fillers work by injecting hyaluronic acid into areas of facial contours that lack volume. Hyaluronic acid is already naturally occurring in the body and mimics how collagen settles underneath your skin. The procedure also boosts collagen production, giving you longer-lasting results that continue to improve over time.
At the Med Lounge, we use what we know to be the best facial filler: JUVÉDERM.
That said, there are some variations even when it comes to that brand. Each JUVÉDERM product will vary somewhat in its viscosity and strength. The dosages we recommend are based on the product you choose for your treatment.
JUVÉDERM products we offer at the Med Lounge include:
- JUVÉDERM XC: Smooth smile lines and wrinkles around your nose and mouth.
- JUVÉDERM Ultra & Ultra Plus XC: Give your lips that sexy fullness or smooth moderate to severe smile lines.
- JUVÉDERM VOLBELLA XC: Subtly boost your lip volume with lip injections and soften vertical lip lines.
- JUVÉDERM VOLLURE XC: Soften moderate to severe fine lines and wrinkles.
- JUVÉDERM VOLUMA XC: Plump up flat cheeks for a more elevated, youthful look.
If you’re unsure about the right product for your goals, come in for a consultation. Our staff will help you decide based on what you’re looking to accomplish with your cosmetic treatment. That may even mean a combination treatment with Botox or choosing Botox injections instead.
Most JUVÉDERM dermal filler appointments only last 15-20 minutes. Once you’re done, there’s zero downtime, allowing you to go about your day right out of the office.
The treatment itself is non-invasive, and many patients compare the pain level to a Botox treatment. Injections are quick and precise, but there can be some discomfort when working with more sensitive areas of the face. If you’re particularly sensitive to pain, talk to our staff. We can put you at ease with the ways we manage our patients’ comfort during the procedure. At Med Lounge, we use topical anesthetics and a numbing agent where the injections take place. If you choose to go with JUVÉDERM XC, those products already contain lidocaine to manage any discomfort with your treatment effectively.
There is a wide range of timelines regarding what to expect out of your dermal fillers. The type of filler used, the area of the face you’re targeting, and your daily habits all contribute to how long dermal fillers will last. Most should expect their fillers to last between 9 months to a year, with some fillers lasting even up to two years.
JUVÉDERM fillers use hyaluronic acid, a naturally occurring substance in the body. This means there is a near-zero risk of an allergic reaction when using these dermal fillers. Mild side effects are rare, but some patients experience redness, swelling or bruising at the injection sites. More severe side effects are even less common but can include lumps, infections or skin discoloration.
If you’re pregnant or breastfeeding, suffer from a neurological disorder or have a known allergy to any of the listed ingredients, you should not have dermal fillers.
The best way to ensure a smooth treatment is to go with an experienced treatment provider. Our well-trained staff is ready to give you the dermal filler before and after you’re envisioning right now. If for whatever reason, you’re unhappy with your dermal fillers, they’re also reversible. We can safely dissolve your fillers at your next appointment.
See the amazing difference in our clients, before and after treatment.


Ashlyn – Chin


Avi – Chin


Dylan – Chin


Laura – Facial Wrinkles & Lines


Diana – Lips


Michael – Smile Lines
What to Expect With Dermal Fillers
For the best results and to reduce the chance of any side effects after your treatment, our experts at the Med Lounge have a few tips around what to expect with dermal fillers before and after your procedure.
PRE-TREATMENT
- Let your doctor know if you have a history of cold sores. You’ll need a prescription to get rid of any active infection or prevent an infection after your treatment.
- Avoid any anti-inflammatories or blood-thinning medications up to two weeks before your treatment. Those include but aren’t limited to aspirin, Motrin, ibuprofen, and Aleve. If you take daily aspirin for a history of heart disease, talk to your doctor before stopping your aspirin routine.
- Avoid any herbal supplements up to two weeks before your treatment. Those include but aren’t limited to garlic, ginseng, vitamin E, omega-3, fish oil, ginkgo biloba and St. John’s Wort.
- Give your filler at least two weeks to settle and allow for any bruising or swelling to go away before scheduling any special events.
- Avoid drinking alcohol the week of your treatment.
- Consider taking Arnica tablets several days ahead of your treatment. Arnica could help prevent bruising at your injection sites.
- Be gentle with your face in the days approaching your treatment. That means no bleaching, waxing or tweezing. Avoid topical products and anti-aging serums. Go natural for the time being so that your skin isn’t more sensitive than usual.
POST-TREATMENT
- Avoid spending too much time out in the sun for the first few days post-treatment. Don’t forget to apply sunscreen whenever you go out, even well after the initial treatment phase.
- Avoid touching or massaging your face for the first 24 hours after your fillers.
- Some swelling or redness is a normal reaction. For any discomfort, you can take acetaminophen and gently apply a cool compress to any tender spots for about 10 minutes every hour.
- Try sleeping face up and slightly elevated in the first few nights after treatment.
- Avoid alcohol, strenuous exercise and any heavy lifting for the first 24 hours after your treatment. This can all cause additional bruising, extending your healing time.
- Give yourself at least four weeks between fillers and any additional cosmetic treatments.
- Call your doctor if you have any serious side effects, such as severe pain, fever or skin discoloration, or if you’re unhappy with your results. Dermal fillers are reversible, but you’ll want to give your treatment a few days to settle before making a decision. More likely than not, you’ll be showing off that subtle new glow in no time.
JUVÉDERM® Collection of Fillers Important Information
INDICATIONS
JUVÉDERM® VOLUMA™ XC is indicated for deep (subcutaneous and/or supraperiosteal) injection for cheek augmentation to correct age-related volume deficit in the mid-face and for augmentation of the chin region to improve the chin profile in adults over the age of 21.
JUVÉDERM® VOLLURE™ XC injectable gel is indicated for injection into the mid-to-deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) in adults over the age of 21.
JUVÉDERM® Ultra Plus XC and JUVÉDERM® Ultra XC injectable gels are indicated for injection into the mid-to-deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds).
JUVÉDERM® VOLBELLA™ XC injectable gel is indicated for injection into the lips for lip augmentation and for correction of perioral rhytids in adults over the age of 21.
JUVÉDERM® Ultra XC injectable gel is indicated for injection into the lips and perioral area for lip augmentation in adults over the age of 21.
IMPORTANT SAFETY INFORMATION
CONTRAINDICATIONS
These products should not be used in patients who have severe allergies, marked by a history of anaphylaxis or history or presence of multiple severe allergies, and should not be used in patients with a history of allergies to Gram-positive bacterial proteins or lidocaine contained in these products.
WARNINGS
- Do not inject into blood vessels. Introduction of these products into the vasculature may lead to embolization, occlusion of the vessels, ischemia, or infarction. Take extra care when injecting soft-tissue fillers; for example, inject the product slowly and apply the least amount of pressure necessary. Rare, but serious, adverse events associated with the intravascular injection of soft-tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage leading to stroke, skin necrosis, and damage to underlying facial structures. Immediately stop the injection if a patient exhibits any of the following symptoms: changes in vision, signs of a stroke, blanching of the skin, unusual pain during or shortly after the procedure. Patients should receive prompt medical attention and, possibly, evaluation by an appropriate healthcare professional specialist should an intravascular injection occur
- Product use at specific sites in which an active inflammatory process (skin eruptions such as cysts, pimples, rashes, or hives) or infection is present should be deferred until the underlying process has been controlled
PRECAUTIONS
- To minimize the risk of potential complications, these products should only be used by healthcare professionals who have appropriate training, experience, and knowledge of facial anatomy and product use in indicated areas
- The potential risks of soft-tissue injections should be discussed with patients prior to treatment to ensure they are aware of signs and symptoms of complications
- The safety and effectiveness for the treatment of anatomic regions other than the mid-face, chin, and prejowl sulcus regions with JUVÉDERM® VOLUMA™ XC; facial wrinkles and folds with JUVÉDERM® VOLLURE™ XC, JUVÉDERM® Ultra Plus XC, and JUVÉDERM® Ultra XC; and the lips and perioral area with JUVÉDERM® VOLBELLA™ XC and JUVÉDERM® Ultra XC have not been established in controlled clinical studies
- The safety for use of these products during pregnancy, in breastfeeding females, and in patients with known susceptibility to keloid formation, hypertrophic scarring, and pigmentation disorders has not been studied
- The safety for use of JUVÉDERM® VOLUMA™ XC has been established in patients between 35 and 65 years of age in cheek augmentation and for patients between 22 and 80 years of age for chin augmentation
- The safety for use of JUVÉDERM® Ultra Plus XC and JUVÉDERM® Ultra XC in patients under 18 years, and JUVÉDERM® VOLLURE™ XC and JUVÉDERM® VOLBELLA™ XC in patients under 22 years, has not been established
- As with all transcutaneous procedures, dermal filler implantation carries a risk of infection
- Use dermal fillers with caution in patients on immunosuppressive therapy
- Patients who are using products that can prolong bleeding (such as aspirin, nonsteroidal anti-inflammatory drugs, and warfarin) may experience increased bruising or bleeding at treatment sites
- Patients who experience skin injury near the site of implantation may be at a higher risk for adverse events
- The safety for use of JUVÉDERM® VOLUMA™ XC injectable gel in patients with very thin skin in the mid-face has not been established
- The safety of JUVÉDERM® VOLUMA™ XC with cannula for cheek augmentation has not been established in patients with Fitzpatrick Skin Types V and VI
- JUVÉDERM® VOLUMA™ XC was not evaluated in subjects with significant skin laxity of the chin, neck, or jaw in the chin augmentation study
- The effect of JUVÉDERM® VOLUMA™ XC injection into the chin on facial hair growth has not been studied
- Patients may experience late onset nodules with use of dermal fillers including JUVÉDERM® VOLUMA™ XC
- Patients may experience late onset adverse events with use of dermal fillers
ADVERSE EVENTS
The most commonly reported side effects for JUVÉDERM® injectable gels were redness, swelling, pain, tenderness, firmness, lumps/bumps, bruising, discoloration, and itching. For JUVÉDERM® VOLBELLA™ XC, dryness was also reported. The majority were mild or moderate in severity. For JUVÉDERM® VOLUMA™ XC, most resolved within 2 to 4 weeks. For JUVÉDERM® VOLLURE™ XC, JUVÉDERM® Ultra Plus XC, or JUVÉDERM® Ultra XC, most resolved within 14 days; and for JUVÉDERM® VOLBELLA™ XC, most resolved within 30 days.
To report an adverse reaction with any product in the JUVÉDERM® Collection, please call Allergan at 1-800-433-8871. Please visit JuvedermDFU.com for more information.
Products in the JUVÉDERM® Collection are available only by a licensed physician or properly licensed practitioner.
Botox Option #1
Everything You Need-
Most Popular Option
-
Minimum 10 Units
-
Competitive Pricing
Botox Option #2
Long Term Value-
For Long Term Goals
-
Minimum 30 Units
-
Best Overall Value
Botox Option #3
Yearly Unlimited Membership-
Unlimited Visits
-
Refer A Friend Rewards
-
Bonus Benefits



BOTOX® Cosmetic (onabotulinumtoxinA) Important Information
Indications
BOTOX® Cosmetic (onabotulinumtoxinA) is indicated in adult patients for the temporary improvement in the appearance of:
– Moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity
– Moderate to severe lateral canthal lines associated with orbicularis oculi activity
– Moderate to severe forehead lines associated with frontalis activity
IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING
WARNING: DISTANT SPREAD OF TOXIN EFFECT
Postmarketing reports indicate that the effects of BOTOX® Cosmetic and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity, but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have an underlying condition that would predispose them to these symptoms. In unapproved uses and approved indications, cases of spread of effect have been reported at doses comparable to those used to treat cervical dystonia and spasticity and at lower doses.
CONTRAINDICATIONS
BOTOX® Cosmetic is contraindicated in the presence of infection at the proposed injection site(s) and in individuals with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation.
WARNINGS AND PRECAUTIONS
Lack of Interchangeability Between Botulinum Toxin Products
The potency units of BOTOX® Cosmetic are specific to the preparation and assay method utilized. They are not interchangeable with other preparations of botulinum toxin products and, therefore, units of biological activity of BOTOX® Cosmetic cannot be compared to nor converted into units of any other botulinum toxin products assessed with any other specific assay method.
Spread of Toxin Effect
Please refer to Boxed Warning for Distant Spread of Toxin Effect.
No definitive serious adverse event reports of distant spread of toxin effect associated with dermatologic use of BOTOX® Cosmetic at the labeled dose of 20 Units (for glabellar lines), 24 Units (for lateral canthal lines), 40 Units (for forehead lines with glabellar lines), 44 Units (for simultaneous treatment of lateral canthal lines and glabellar lines), and 64 Units (for simultaneous treatment of lateral canthal lines, glabellar lines, and forehead lines) have been reported. Patients or caregivers should be advised to seek immediate medical care if swallowing, speech, or respiratory disorders occur.
Serious Adverse Reactions With Unapproved Use
Serious adverse reactions, including excessive weakness, dysphagia, and aspiration pneumonia, with some adverse reactions associated with fatal outcomes, have been reported in patients who received BOTOX® injections for unapproved uses. In these cases, the adverse reactions were not necessarily related to distant spread of toxin, but may have resulted from the administration of BOTOX® to the site of injection and/or adjacent structures. In several of the cases, patients had pre-existing dysphagia or other significant disabilities. There is insufficient information to identify factors associated with an increased risk for adverse reactions associated with the unapproved uses of BOTOX®. The safety and effectiveness of BOTOX® for unapproved uses have not been established.
Hypersensitivity Reactions
Serious and/or immediate hypersensitivity reactions have been reported. These reactions include anaphylaxis, serum sickness, urticaria, soft-tissue edema, and dyspnea. If such reactions occur, further injection of BOTOX® Cosmetic should be discontinued and appropriate medical therapy immediately instituted. One fatal case of anaphylaxis has been reported in which lidocaine was used as the diluent and, consequently, the causal agent cannot be reliably determined.
Cardiovascular System
There have been reports following administration of BOTOX® of adverse events involving the cardiovascular system, including arrhythmia and myocardial infarction, some with fatal outcomes. Some of these patients had risk factors including pre-existing cardiovascular disease. Use caution when administering to patients with pre-existing cardiovascular disease.
Increased Risk of Clinically Significant Effects With Pre-existing Neuromuscular Disorders
Individuals with peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, or neuromuscular junction disorders (eg, myasthenia gravis or Lambert-Eaton syndrome) should be monitored when given botulinum toxin. Patients with neuromuscular disorders may be at increased risk of clinically significant effects including generalized muscle weakness, diplopia, ptosis, dysphonia, dysarthria, severe dysphagia, and respiratory compromise from onabotulinumtoxinA (see Warnings and Precautions).
Dysphagia and Breathing Difficulties
Treatment with BOTOX® and other botulinum toxin products can result in swallowing or breathing difficulties. Patients with pre-existing swallowing or breathing difficulties may be more susceptible to these complications. In most cases, this is a consequence of weakening of muscles in the area of injection that are involved in breathing or oropharyngeal muscles that control swallowing or breathing (see Boxed Warning).
Pre-existing Conditions at the Injection Site
Caution should be used when BOTOX® Cosmetic treatment is used in the presence of inflammation at the proposed injection site(s) or when excessive weakness or atrophy is present in the target muscle(s).
Dry Eye in Patients Treated With BOTOX® Cosmetic
There have been reports of dry eye associated with BOTOX® Cosmetic injection in or near the orbicularis oculi muscle. If symptoms of dry eye (eg, eye irritation, photophobia, or visual changes) persist, consider referring patients to an ophthalmologist.
Human Albumin and Transmission of Viral Diseases
This product contains albumin, a derivative of human blood. Based on effective donor screening and product manufacturing processes, it carries an extremely remote risk for transmission of viral diseases and variant Creutzfeldt-Jakob disease (vCJD). There is a theoretical risk for transmission of Creutzfeldt-Jakob disease (CJD), but if that risk actually exists, the risk of transmission would also be considered extremely remote. No cases of transmission of viral diseases, CJD or vCJD have ever been identified for licensed albumin or albumin contained in other licensed products.
ADVERSE REACTIONS
The most frequently reported adverse reactions following injection of BOTOX® Cosmetic for glabellar lines were eyelid ptosis (3%), facial pain (1%), facial paresis (1%), and muscular weakness (1%).
The most frequently reported adverse reaction following injection of BOTOX® Cosmetic for lateral canthal lines was eyelid edema (1%).
The most frequently reported adverse reactions following injection of BOTOX® Cosmetic for forehead lines with glabellar lines were headache (9%), brow ptosis (2%), and eyelid ptosis (2%).
DRUG INTERACTIONS
Co-administration of BOTOX® Cosmetic and aminoglycosides or other agents interfering with neuromuscular transmission (eg, curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated. Use of anticholinergic drugs after administration of BOTOX® Cosmetic may potentiate systemic anticholinergic effects.
The effect of administering different botulinum neurotoxin products at the same time or within several months of each other is unknown. Excessive neuromuscular weakness may be exacerbated by
administration of another botulinum toxin prior to the resolution of the effects of a previously administered botulinum toxin.
Excessive weakness may also be exaggerated by administration of a muscle relaxant before or after administration of BOTOX® Cosmetic.
USE IN SPECIFIC POPULATIONS
There are no studies or adequate data from postmarketing surveillance on the developmental risk associated with use of BOTOX® Cosmetic in pregnant women. There are no data on the presence of BOTOX® Cosmetic in human or animal milk, the effects on the breastfed child, or the effects on milk production.
Please see BOTOX® Cosmetic full Prescribing Information including Boxed Warning and Medication Guide.